Short-termed expression of interleukin-12 during experimental BLV infection may direct disease progression to

B Yakobson1, J Brenner, H Ungar-Waron

  • 1Department of Immunology, Kimron Veterinary Institute, Beit-Dagan, Israel.

Insights

This study reveals how cattle infected with bovine leukemia virus (BLV) mount an immune response. Early cell-mediated immunity shifts to a later IL-10 driven humoral response, influencing disease progression.

Area of Science:

  • Veterinary Immunology
  • Virology
  • Molecular Biology

Background:

  • Bovine leukemia virus (BLV) causes persistent lymphocytosis (PL+) in cattle.
  • Understanding the cellular immune response to BLV is crucial for disease management.

Purpose of the Study:

  • To elucidate cytokine expression during experimental BLV infection in cattle.
  • To correlate cytokine profiles with disease progression stages.

Main Methods:

  • Monitoring BLV infection using BLV gp51 mRNA expression and PCR/RT-PCR.
  • Detecting antibodies via agar gel immuno-diffusion (AGID) test.
  • Quantifying cytokine mRNA expression (IL-12p40, TNFalpha, IL-1beta, IFNgamma, IL-2, IL-10) in peripheral blood mononuclear cells (PBMCs).

Main Results:

  • Antibodies detected at 5 weeks; PL+ established by 24 weeks.
  • Initial IL-12p40 expression observed 1-3 weeks post-infection.
  • Pro-inflammatory and cellular cytokines (TNFalpha, IL-1beta, IFNgamma, IL-2) detected from week 2-3.
  • IFNgamma decreased by week 12, while IL-10 increased and persisted.

Conclusions:

  • BLV infection induces a transient cell-mediated immune response (IL-12p40, IFNgamma).
  • A shift towards an IL-10 mediated humoral response occurs early in infection.
  • Altered cytokine balance may drive disease progression to the persistent lymphocytosis stage.

Related Concept Videos